Retail News CRM

Tag: mergers and acquisitions

  • Graas Raises US$17 Million and Buys Trustana to Expand Retail AI Tools

    Graas Raises US$17 Million and Buys Trustana to Expand Retail AI Tools

    Singapore e-commerce technology platform Graas has raised US$17 million in fresh capital and completed the acquisition of product data company Trustana.

    The transaction brings Trustana’s catalogue and product intelligence software directly into Graas’s automated operating system for consumer brands across the region.

    Integrating Product Data

    Graas builds artificial intelligence software designed to optimize inventory, ad spend, and pricing decisions across digital marketplaces. Adding Trustana, an enterprise data startup initially incubated by Temasek, gives the combined entity deeper capability in structuring product catalogues and syndicating retail data across fragmented sales channels.

    Brand operators across Southeast Asia frequently run concurrent storefronts on Shopee, Lazada, TikTok Shop, and standalone web platforms. Managing product data across those channels remains one of the most persistent operational bottlenecks in regional digital commerce.

    Consolidation in E-Commerce Tech

    Software vendors across the region are consolidating capabilities as enterprise clients push to trim their technology vendor counts. Graas previously expanded its footprint by acquiring specialized marketing and logistics analytics companies across India and Southeast Asia.

    RetailNews Asia views the deal as a clear shift away from standalone point solutions toward unified enterprise software suites capable of running daily merchant operations autonomously.

    Integration of Trustana’s data pipelines into the Graas platform begins immediately, with the combined software suite scheduled for enterprise rollout over the coming quarter.

  • Sigma Healthcare Profit Jumps 22 per Cent as Annual Sales Top $10.8 Billion

    Sigma Healthcare Profit Jumps 22 per Cent as Annual Sales Top $10.8 Billion

    Sigma Healthcare posted a 22.3 per cent rise in annual net profit to $732.3 million for the year ended June 30, lifted by pharmacy additions and GLP-1 prescription volumes.

    Group revenue advanced 15.5 per cent to $10.8 billion, while normalised earnings before interest and taxes climbed 20.6 per cent to breach $1 billion.

    The results reflect the first full operating cycle since Sigma combined operations with discount chain Chemist Warehouse. Chief Executive Officer Vikesh Ramsunder told investors the business now oversees nearly 1,000 pharmacies worldwide, supported by supply-chain integration across wholesale and retail divisions.

    Chemist Warehouse Drives Domestic Momentum

    Australia generated the bulk of earnings, lifting revenue 14.9 per cent to $10.4 billion and normalised operating profit by 18.3 per cent. Chemist Warehouse added 24 domestic sites to reach 561 stores, generating network sales growth of 15.9 per cent and same-store sales gains of 13.4 per cent.

    Sales of GLP-1 weight-loss medications contributed heavily to turnover across the network. While the high-cost treatments carry lower percentage returns, Sigma maintained its Australian gross margin at 17.6 per cent by expanding front-of-store retail lines, introducing more than 470 private-label products during the financial year.

    For retail pharmacy chains across the Asia-Pacific region, Sigma’s post-merger run shows how high-volume discount models can protect margins even as prescription product mixes shift toward expensive, low-margin therapies. It also demonstrates how domestic retail density provides cash flow stability after walking away from risky international takeovers, including Sigma’s abandoned $14 billion tilt at Britain’s Boots chain.

    Synergies and Franchise Pipeline

    Sigma captured $32.6 million in operational savings during the year as it works toward an annual cost-reduction target of $100 million by the 2029 financial year.

    Wholesale franchise networks Amcal and Discount Drug Stores are also rebuilding footprint after years of store rationalisation. Management has assembled an opening pipeline of 82 stores, scheduled to return both banner groups to net store count growth during the 2027 financial year.

  • KKR Agrees to Buy Japanese Beauty Platform Ci Flavours

    KKR Agrees to Buy Japanese Beauty Platform Ci Flavours

    KKR has agreed to acquire Japanese personal care platform Ci Flavours from existing shareholders, including consumer buyout specialist L Catterton.

    The buyout firm will take full ownership from all current equity holders, which include founder Yusaku Horiuchi, Ebeauty Group and Yanagi Capital Partners. Financial terms were not disclosed.

    Horiuchi and Ci Flavours chief executive Yoshiaki Okura will reinvest alongside KKR to retain management stakes in the company. Founded in 2011, the Tokyo-based firm built a retail footprint across Japan and expanded overseas distribution into Asia and North America.

    Brand roster and overseas distribution

    Ci Flavours operates a portfolio spanning haircare, skincare, body care and lifestyle goods. Its primary labels include &Honey, 8 The Thalasso, Unlabel, Theratis and Moroccan Beauty.

    The business handles product lines through multiple channels, including original equipment manufacturing, direct-to-consumer digital storefronts, department store counters and international ingredient sourcing. Mass-market and premium haircare lines in domestic drugstores provided the company with steady cash flow to push into regional export markets.

    Private equity shifts in Japanese consumer assets

    L Catterton backed Ci Flavours in 2022, completing an exit four years later as global private equity funds continue trading established Japanese consumer brands. KKR has actively adjusted its regional consumer portfolio, having completed the sale of supermarket chain Seiyu to Trial Holdings for US$2.55 billion.

    Okura and his executive team plan to deploy fresh capital into foreign market distribution, recruitment and targeted add-on acquisitions in personal care.

  • New Zealand Clears Kimberly-Clark Kenvue Deal with Feminine Hygiene Divestment

    New Zealand Clears Kimberly-Clark Kenvue Deal with Feminine Hygiene Divestment

    New Zealand’s Commerce Commission has approved Kimberly-Clark’s acquisition of Kenvue. Clearance requires the business to divest Kenvue’s feminine hygiene operations across New Zealand and Australia.

    This divestment covers regional rights to brands including Carefree and Stayfree. The condition aims to prevent excessive market concentration on supermarket shelves.

    Conditions for Clearance Across Australasia

    Kimberly-Clark is acquiring Kenvue, the consumer health spin-off from Johnson & Johnson, in a global takeover. Under an undertaking given to the regulator, Kimberly-Clark must sell the entire Kenvue feminine care unit in both countries to an approved independent buyer.

    Commerce Commission deputy chair Anne Callinan said the remedy protects competition across personal care aisles, where both suppliers held overlapping product lines.

    Supermarket Consolidation and Buyer Timelines

    Australasian retailers face tightening supplier networks as multinational consumer goods groups consolidate personal care portfolios. Selling Carefree and Stayfree keeps an independent supplier in play against Kimberly-Clark’s Kotex and U by Kotex lines.

    Attention now turns to the asset sale. Kimberly-Clark must secure a commission-approved buyer within a confidential, binding timeframe to finalize the broader merger clearance.